

A company called Calmara offers an AI tool to assess STI risk based on a photo of a partner's genitals, but experts warn against its reliability and privacy concerns. Calmara's approach is criticized for its misleading marketing and lack of medical validation, contrasting with more responsible STI testing startups like HeHealth. The privacy policy raises questions about data security and potential legal issues, highlighting the dangers of over-hyped technology in the sensitive area of sexual health.


A company called Calmara offers an AI tool to assess STI risk based on a photo of a partner's genitals, but experts warn against its reliability and privacy concerns. Calmara's approach is criticized for its misleading marketing and lack of medical validation, contrasting with more responsible STI testing startups like HeHealth. The privacy policy raises questions about data security and potential legal issues, highlighting the dangers of over-hyped technology in the sensitive area of sexual health.
•Misleading marketing and lack of medical validation raise concerns about Calmara's approach.
•Privacy policy of Calmara and HeHealth sparks worries about data security and legal implications.
•Over-hyped technology in sexual health space poses serious consequences for users and companies.
Need any assistance with your queries?
Our AI chatbot support is always available to provide answers to any questions but to begin with, here are some of our most asked questions
What are the main concerns surrounding Calmara's AI STI testing tool?
How does HeHealth differ from Calmara in addressing STI testing?
Why is data privacy a significant issue with Calmara and HeHealth's AI tools?







